Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.
DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.
For clinical applications, simplicity, high efficiency, and low toxicity are key issues in the design of anti-tumor drugs. In this work, a novel dual-responsive drug self-framed delivery system (DSFDS) with high drug delivery efficiency is proposed based on self-framing of an anticancer drug and a tumor-responsive molecule within phosphazene nanoparticles through a simple condensation polymerization method under mild conditions. Due to a unique structural feature of polyphosphazenes, the nanodrug-delivery system showed pH responsiveness. Furthermore, the DSFDS was endowed with glutathione (GSH)-responsiveness by incorporating a cysteine derivative into the polyphosphazene nanoparticles. The dual-responsive DSFDS has been demonstrated to retain high stability during blood circulation and high sensitivity to tumor micromilieu (lower pH in lysosomes and higher GSH concentration in cytoplasm). A super high drug-loading capacity of over 78 wt% made it possible to reduce the usage of the drug and relieve metabolic stress. The proposed DSFDS showed promising potential for highly efficient and controllable release of cancer therapeutics.
Christian Heinis, Alexander Lund Nielsen, Xinjian Ji
Julia Schmale, Hélène Paule Angot